There is no magical amount of viable ventricular myocardium that makes percutaneous coronary intervention (PCI) an effective addition to optimal medical therapy (OMT) in stable patients with coronary ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — PCI may not improve survival or left ventricular recovery among patients with ischemic ...

Photo Credit: Adapted from Perera D. Revascularization in LV systolic dysfunction: revived or dead? Presented at: TCT 2022. Boston, MA. NEW ORLEANS, LA—No matter what the viability testing shows, ...

"...in clinical practice, a large number of these [nonviable] patients do actually undergo intervention, and I think it would be helpful to know if we are actually ...

More than half of student athletes at a single university had some degree of inflammation detected on cardiac magnetic resonance (CMR) imaging or echocardiography following mild or asymptomatic ...

Two new studies on diastolic heart failure are starting at the German Centre for Cardiovascular Research (DZHK). They will investigate whether this form of heart failure can be better diagnosed and ...

AWANS, Belgium--(BUSINESS WIRE)--Miracor Medical SA (Miracor Medical) has announced the approval of an Investigational Device Exemption (IDE) from the FDA, enabling the company to initiate a pivotal ...